Leap Therapeutics Inc LPTX:NASDAQ

Last Price$1.20NASDAQ Closing Price as of 4:00PM ET 5/26/22

Today's Change+0.01(0.84%)
Bid (Size)$1.17 (2)
Ask (Size)$1.19 (1)
Day Low / High$1.16 - 1.22
Volume770.5 K

Sector Update: Health Care Stocks Edge Higher Premarket Wednesday

9:12AM ET 1/19/2022 MT Newswires
Health care stocks were edging higher premarket Wednesday. The iShares Biotechnology ETF (IBB) was up by 0.64% while the Health Care SPDR (XLV) was 0.02% higher recently.

Zogenix (ZGNX) was rallying past 67% after saying it has agreed to be acquired by Belgian pharmaceutical company UCB in a deal worth up to roughly $1.9 billion. Under the terms of the deal, UCB will launch a tender offer to acquire Zogenix for $26 per share in cash, plus a potential $2 per share in a contingent value right payment.

Leap Therapeutics (LPTX) was gaining more than 6% after saying late Tuesday the combination of anti-Dickkopf-1, or DKN-01, with tislelizumab "continues to demonstrate encouraging results" in patients with gastric and gastroesophageal junction cancer.

UnitedHealth Group (UNH) was more than 1% higher as it posted a Q4 adjusted diluted profit of $4.48 per share, up from $2.52 per share a year earlier. Analysts polled by Capital IQ expected earnings of $4.31 per share.